Free Trial

Merck & Co., Inc. (MRK) SEC Filings & 10K Form

Merck & Co., Inc. logo
$101.32
-0.55 (-0.54%)
(As of 11:11 AM ET)

Recent Merck & Co., Inc. SEC Filings

DateFilerForm TypeView
10/31/2024
5:44 AM
Merck & Co., Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
1:06 PM
Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
1:10 PM
GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
1:16 PM
Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
11:20 AM
Guindo Chirfi (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
5:41 AM
Merck & Co., Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
12:20 PM
Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
12:23 PM
GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
12:25 PM
Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
12:37 PM
Merck & Co., Inc. (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/25/2024
12:37 PM
Merck & Co., Inc. (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/25/2024
12:38 PM
Merck & Co., Inc. (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/04/2024
1:55 PM
Merck & Co., Inc. (Issuer)
Rothman Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
1:59 PM
Merck & Co., Inc. (Issuer)
Warden Kathy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
2:00 PM
Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
2:02 PM
Merck & Co., Inc. (Issuer)
RUSSO PATRICIA F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
1:41 PM
Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
1:44 PM
BAKER DOUGLAS M JR (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
1:44 PM
Merck & Co., Inc. (Issuer)
THULIN INGE G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
1:32 PM
Mayo Stephen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
1:34 PM
GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
1:38 PM
Craig Pamela J. (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
1:15 PM
LAVIZZO-MOUREY RISA J (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
3:39 PM
Merck & Co., Inc. (Filer)
Form CERT
05/20/2024
5:28 AM
Merck & Co., Inc. (Filer)
MSD Netherlands Capital B.V. (Filer)
Form 424B5
05/15/2024
10:31 AM
Merck & Co., Inc. (Filer)
MSD Netherlands Capital B.V. (Filer)
Form POSASR
05/06/2024
3:29 PM
Merck & Co., Inc. (Subject)
MIZELL STEVEN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2024
3:15 PM
Merck & Co., Inc. (Issuer)
Oosthuizen Johannes Jacobus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:17 PM
Li Dean Y (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:19 PM
Merck & Co., Inc. (Issuer)
Zachary Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2024
5:41 AM
Merck & Co., Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
3:05 PM
Merck & Co., Inc. (Filer)
Form 10-K/A
04/11/2024
3:08 PM
Merck & Co., Inc. (Filer)
Form DEF 14A
04/11/2024
3:10 PM
Merck & Co., Inc. (Filer)
Form DEFA14A
04/11/2024
3:12 PM
Merck & Co., Inc. (Filer)
Form ARS
04/08/2024
12:56 PM
Larson Betty D (Reporting)
Merck & Co., Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/01/2024
4:16 PM
Inspire Investing, LLC (Filed by)
Merck & Co., Inc. (Subject)
Form PX14A6G
03/29/2024
3:12 PM
Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:14 PM
GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:16 PM
Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:18 PM
Merck & Co., Inc. (Issuer)
WENDELL PETER C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Top 10 AI Stocks to Buy Now (Ad)

Are you ready to capitalize on the booming AI market? Our experts have identified the top 10 AI stocks set to skyrocket.

03/27/2024
7:57 PM
Bowyer Research, Inc. (Filed by)
Merck & Co., Inc. (Subject)
Form PX14A6G
03/11/2024
2:27 PM
Harpoon Therapeutics, Inc. (Issuer)
Merck & Co., Inc. (Reporting)
MERCK SHARP & DOHME LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
3:24 PM
Davis Robert M (Reporting)
Merck & Co., Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2024
3:01 PM
Merck & Co., Inc. (Issuer)
Oosthuizen Johannes Jacobus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
3:35 PM
Merck & Co., Inc. (Subject)
Oosthuizen Johannes Jacobus (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/01/2024
5:39 AM
Merck & Co., Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2024
2:29 PM
Evaxion Biotech A/S (Subject)
Merck & Co., Inc. (Filed by)
Form SC 13G
01/17/2024
4:52 PM
Harpoon Therapeutics, Inc. (Issuer)
Merck & Co., Inc. (Reporting)
MERCK SHARP & DOHME LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:27 PM
Merck & Co., Inc. (Issuer)
WENDELL PETER C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
3:18 PM
Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
4:27 PM
Merck & Co., Inc. (Issuer)
Smart Dalton (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2023
6:36 AM
Merck & Co., Inc. (Issuer)
Oosthuizen Johannes Jacobus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2023
8:04 AM
DeLuca Richard R. (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:MRK) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners